A Vancouver-based biotech company brought its genetic know-how to Pfizer's COVID-19 vaccine development. Thomas Madden, president and CEO of Acuitas Therapeutics, explains his company's contribution to the vaccine effort.

Pieter Cullis remembers giving a talk at Pfizer in March 2020, just days before Canada implemented stay-at-home measures to curb the deadly COVID-19 pandemic. Five years later, and after the mRNA vaccine technology he worked on found its...

Measuring DNA or protein concentration

Researchers are looking at ways messenger RNA technology from COVID-19 vaccines can be used to fight other illnesses and diseases.

Jun.30 -- What if we could arm cells with the tools they need to eliminate certain types of cancer? That is the ultimate end goal for Caribou Biosciences, a Berkeley, California-based genome-editing biopharmaceutical...

Apr.09 -- The mRNA technology at the heart of two Covid-19 shots has been decades in the making. Now it may soon be used to fight cancer and HIV. (Video by Vicky Feng)

Germany's BioNTech, which together with Pfizer developed the first mRNA vaccine against the coronavirus, unveils mobile vaccine production units housed in shipping containers at a press conference with the Director General of the WHO...

World Health Organization Director General Tedros Adhanom Ghebreyesus praises South Africa for its "transparency" after identifying the Omicron variant, adding that "identifying variants (...) should be rewarded, not punished", as he...

Apr.19 -- Dr. Robert Gallo, co-founder of the Global Virus Network and director of the Institute of Human Virology at the University of Maryland School of Medicine, discusses the global rollout of Covid-19 vaccines. Global cases passed...

The World Health Organization set up a global mRNA technology transfer hub in South Africa in 2021 to support manufacturers in low- and middle-income countries to produce their own Covid-19 vaccines (Footage by AFPTV via Getty Images)

Jan.28 -- Dr. Stephen Hoge, Moderna Inc. president, discusses the efforts to contain the spread of the deadly coronavirus. He speaks with Bloomberg's Paul Allen and Taylor Riggs.

STOCKSHOTS of the mRNA production for the anti-Covid19 vaccine of BioNtech in a lab in Marburg, Germany (Footage by AFPTV via Getty Images)

Rwandan President Paul Kagame, African Union Commission Chairperson Moussa Faki Mahamat, WHO Director Tedros Adhanom Ghebreyesus, BioNTech CEO Ugur Sahin, and Rwandan and African officials inaugurate the start of construction of...

Interview with Valeska Schilling, Head of Production at the BioNTech site in Marburg, on the production of mRNA, which, when injected, will allow the immune system to prepare for a Covid-19 infection (Footage by AFPTV via Getty Images)

Around a hundred protesters march on Government House to demand the resignation of Thai Prime Minister, General Prayut Chan-o-cha, as well as access to mRNA vaccines as the kingdom suffers its worst outbreak - with officially more than...

Rwanda and BioNTech break ground on Africa's first mRNA vaccine factory where cutting-edge treatments for diseases like Covid will be made for millions across the continent (Footage by AFPTV via Getty Images)

Moderna plans to ask the FDA for emergency vaccine approval in early December and says it could make as many as 1 billion doses next year.

El grupo farmacútico alemán BioNThec que desarrolló junto al estadounidense Pfizer la primera vacuna de ARNm contra covid-19, dio a conocer el miércoles unidades de producción en kits, cuyo objetivo es enviarlas a África en el correr de...